Decreased secretion of gonadotropins in a patient with Graves' disease

Exp Clin Endocrinol Diabetes. 1996;104(1):85-8. doi: 10.1055/s-0029-1211427.

Abstract

A 56-year-old female with Graves' disease who presented with decreased secretion of gonadotropins is described. She was admitted to hospital because of her being in a state of confusion. One month before admission she had been diagnosed as having Graves' disease and was treated with methimazole since then. Plasma LH and FSH levels were undetectable, and their responses to LH-RH were extremely decreased in spite of undetectable levels of plasma estradiol and estriol. One year after treatment, both basal and stimulated values of LH and FSH reverted to normal as did those of TSH. Reversible suppression of gonadotropins as described herein has never been reported in cases of Graves' disease.

Publication types

  • Case Reports

MeSH terms

  • Antithyroid Agents / therapeutic use
  • Body Weight
  • Female
  • Follicle Stimulating Hormone / blood*
  • Follicle Stimulating Hormone / metabolism
  • Follow-Up Studies
  • Gonadotropin-Releasing Hormone
  • Graves Disease / blood
  • Graves Disease / drug therapy
  • Graves Disease / physiopathology*
  • Humans
  • Luteinizing Hormone / blood*
  • Luteinizing Hormone / metabolism
  • Methimazole / therapeutic use
  • Middle Aged
  • Thyrotropin / blood
  • Thyroxine / blood
  • Time Factors
  • Triiodothyronine / blood

Substances

  • Antithyroid Agents
  • Triiodothyronine
  • Gonadotropin-Releasing Hormone
  • Methimazole
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Thyrotropin
  • Thyroxine